FDA Inspection 778186 — Scinopharm Taiwan, Ltd.

Scinopharm Taiwan, Ltd. — FEI 3002840477

The FDA completed an inspection of Scinopharm Taiwan, Ltd. on Mar 29, 2012 in Tainan City. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 29, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tainan City (Taiwan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.